Rallybio’s Acquisition of Worldwide License Rights to KY 1066

Wiggin and Dana represented Rallybio Corporation on the acquisition. Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming…